Kubtec, Stratford, Conn, has received an additional patent from the US Patent Office for its technology used for breast specimen imaging using 3D tomosynthesis.
The patent, Specimen Radiography with Tomosynthesis in a Cabinet (Patent Number 9,642,581 B2), was issued on May 9, and refers to technology currently embodied in the KUBTEC Mozart system, an intraoperative specimen imaging system that uses 3D tomosynthesis to give breast surgeons a superior view of their surgical margins. A recent study has demonstrated that the use of this technology enables significant reductions in surgical re-excision rates when compared to the more traditional 2D planar imaging.
“This patent is recognition that our continued investment in new technology specifically for breast cancer specimen imaging is resulting in new products that really make a difference to people’s lives,” says Vikram Butani, CEO at Kubtec. “As the healthcare market shifts its focus to reimbursement based on quality of care and patient satisfaction, we are positioned to provide solutions that impact these metrics by improving surgical accuracy and reducing avoidable re-hospitalizations for breast cancer patients. “
